Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorOzturk, A. Alper
dc.contributor.authorYenilmez, Evrim
dc.contributor.authorOzarda, Mustafa Gueclue
dc.date.accessioned2020-07-09T20:58:57Z
dc.date.available2020-07-09T20:58:57Z
dc.date.issued2019
dc.identifier.issn2073-4360
dc.identifier.urihttps://doi.org/10.3390/polym11101632
dc.identifier.urihttps://hdl.handle.net/11421/24111
dc.descriptionOzturk, A. Alper/0000-0001-9596-0538en_US
dc.descriptionWOS: 000495382700101en_US
dc.descriptionPubMed: 31600969en_US
dc.description.abstractClarithromycin (CLR) is a member of the macrolide antibiotic group. CLR has low systemic oral bioavailability and is a drug of class II of the Biopharmaceutical Classification System. in many studies, using nanoparticles (NPs) as a drug delivery system has been shown to increase the effectiveness and bioavailability of active drug substances. This study describes the development and evaluation of poly (lactic-co-glycolic acid) (PLGA) NPs and chitosan (CS)-coated PLGA NPs for oral delivery of CLR. NPs were obtained by nanoprecipitation technique and characterized in detail, and the effect of three molecular weights (M-w1: 7.000-17.000, M-w2: 38.000-54.000, M-w3: 50.000-190.000) of PLGA and CS coating on particle size (PS), zeta potential (ZP), entrapment efficiency (EE%), and release properties etc. were elucidated. Gastrointestinal stability and cryoprotectant effect tests were performed on the NPs. the PS of the prepared NPs were in the range of 178 to 578 nm and they were affected by the M-w and CS coating. in surface-modified formulations with CS, the ZP of the NPs increased significantly to positive values. EE% varied from 62% to 85%, depending upon the M-w and CS coating. in vitro release studies of CLR-loaded NPs showed an extended release up to 144 h. Peppas-Sahlin and Weibull kinetic model was found to fit best for CLR release from NPs. By the broth microdilution test method, the antibacterial activity of the formulations was determined on Staphylococcus aureus (ATCC 25923), Listeria monocytogenes (ATCC 1911), and Klebsiella pneumoniae (ATCC 700603). the structures of the formulations were clarified by thermal (DSC), FT-IR, and H-1-NMR analysis. the results showed that PS, ZP, EE%, and dissolution rates of NPs were directly related to the M-w of PLGA and CS coating.en_US
dc.description.sponsorshipAnadolu University Scientific Research Project FoundationAnadolu University [1806S238]en_US
dc.description.sponsorshipThis research work was supported by a grant from the Anadolu University Scientific Research Project Foundation (Project number 1806S238).en_US
dc.language.isoengen_US
dc.publisherMdpien_US
dc.relation.isversionof10.3390/polym11101632en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectClarithromycinen_US
dc.subjectPLGAen_US
dc.subjectchitosanen_US
dc.subjectnanoparticlesen_US
dc.subjectmolecular weighten_US
dc.subjectsurface modificationen_US
dc.subjectantibacterial activityen_US
dc.titleClarithromycin-Loaded Poly (Lactic-co-glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effectsen_US
dc.typearticleen_US
dc.relation.journalPolymersen_US
dc.contributor.departmentAnadolu Üniversitesien_US
dc.identifier.volume11en_US
dc.identifier.issue10en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster